Abstract
In the present study we have confirmed that approximately one third of human colorectal carcinomas fail to express the HLA - A,B,C monomorphic determinant reactive with the W6/32 MAb, and 44% express class II HLA antigens as shown by reactivity with NFK-1 MAb. Reduced staining with the W6/32 MAb was not always associated with the loss of beta 2m. In addition, the expression of HLA-A2 and Bw4 class I specific haplotypes on normal colon epithelium and tumour biopsy tissue was assessed. All normal colonic epithelia stained positively with MAb against A2 and Bw4 antigens, but a loss of these determinants was shown on tumour biopsies from patients tissue typed for the respective specificities. Loss of the A2 haplotype was shown in 4 of 15 tumour tissue samples, and loss of Bw4 specificities in 5 out of 7 tissue samples. The failure to detect specific loci determinants was not necessarily associated with loss of reactivity with W6/32 MAb.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rees, R., Buckle, AM., Gelsthorpe, K. et al. Loss of polymorphic A and B locus HLA antigens in colon carcinoma. Br J Cancer 57, 374–377 (1988). https://doi.org/10.1038/bjc.1988.85
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.85
This article is cited by
-
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy
Cellular & Molecular Immunology (2021)
-
Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases
Clinical & Experimental Metastasis (1995)
-
Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas
Cancer Immunology Immunotherapy (1991)